Table 1.
Clinical Information and laboratory findings of patients with non-infectious uveitis and controls.
| BD | Sarcoidosis | VKH | Control | |
|---|---|---|---|---|
| Number | 19 | 20 | 15 | 16 |
| Sex (male/female) | 9/10 | 6/14 | 8/7 | 8/8 |
| Age (year) ± SD (range) | 42.7 ± 16.8 (15–71) | 69.0 ± 11.3 (45–86) | 46.4 ± 15.5 (12–71) | 53.8 ± 18.5 (27–83) |
| WBC (/μL) | 6307.5 | 6204.2 | 6508.3 | - |
| CRP (mg/dL) | 0.11 | 0.09 | 0.08 | - |
| CH50 (U/mL) | 62.1 | 63.8 | 59.1 | - |
| sIL-2R (U/mL) | 410.3 | 810.2 | - | - |
| ACE (IU/L) | 12.1 | 18.4 | 9.2 | - |
| HLA-B51 | 7 (36.8%) | - | - | - |
| HLA-A26 | 8 (42.1%) | - | - | - |
BD: Behҫet’s disease, VKH:Vogt-Koyanagi-Harada disease, SD: standard deviation, WBC: white blood cell, CRP: C-reactive protein, CH50: 50% hemolytic unit of complement, sIL-2R: soluble IL-2 receptor, ACE: angiotensin-converting enzyme, HLA: Human Leukocyte Antigen.